Akoya BioSciences Inc.

11.19+0.6600+6.27%Vol 272.58K1Y Perf -41.69%
Jun 24th, 2022 16:00 DELAYED
BID9.50 ASK17.40
Open10.51 Previous Close10.53
Pre-Market- After-Market11.19
 - -  - -%
Target Price
17.33 
Analyst Rating
Strong Buy 1.17
Potential %
54.87 
Finscreener Ranking
 —    -
Insiders Trans % 3/6/12 mo.
-/-/- 
Value Ranking
★+     42.29
Insiders Value % 3/6/12 mo.
-/-/- 
Growth Ranking
     35.55
Insiders Shares Cnt. % 3/6/12 mo.
-/-/- 
Income Ranking
 —    -
Price Range Ratio 52W %
22.94 
Earnings Rating
Market Cap420.62M 
Earnings Date
9th Aug 2022
Alpha-0.04 Standard Deviation0.13
Beta1.29 

Today's Price Range

10.5111.45

52W Range

8.0221.84

Summary:

Buy

Technical Indicators: Neutral
Moving Averages: Strong Buy
Performance
1 Week
19.68%
1 Month
12.01%
3 Months
1.54%
6 Months
-19.15%
1 Year
-41.69%
3 Years
-
5 Years
-
10 Years
-

TickerPriceChg.Chg.%
AKYA11.190.66006.27
AAPL141.663.39002.45
GOOG2 370.76117.07005.19
MSFT267.708.84003.41
XOM86.901.69001.98
WFC40.762.86007.55
JNJ182.292.63001.46
FB196.640.99000.51
GE67.083.01004.70
JPM117.323.40002.98
Earnings HistoryEstimateReportedSurprise %
Q01 2022-0.37-0.44-18.92
Q04 2021-0.31-0.47-51.61
Q03 2021-0.28-0.31-10.71
Q02 2021-0.23-0.2013.04
Q01 2021-0.15-2.85-1 800.00
----
----
----
Earnings Per EndEstimateRevision %Trend
----
----
----
----
Next Report Date9th Aug 2022
Estimated EPS Next Report-0.34
Estimates Count3
EPS Growth Next 5 Years %-
Volume Overview
Volume272.58K
Shares Outstanding37.59K
Shares Float19.93M
Trades Count2.22K
Dollar Volume3.05M
Avg. Volume119.70K
Avg. Weekly Volume182.03K
Avg. Monthly Volume103.06K
Avg. Quarterly Volume74.00K

Akoya BioSciences Inc. (NASDAQ: AKYA) stock closed at 11.19 per share at the end of the most recent trading day (a 6.27% change compared to the prior day closing price) with a volume of 272.58K shares and market capitalization of 420.62M. Is a component of indices and it is traded on NASDAQ exchange. The company belongs in the Medical Devices & Instruments industry, Healthcare sector and employs 169 people. Akoya BioSciences Inc. CEO is Brian McKelligon.

The one-year performance of Akoya BioSciences Inc. stock is -41.69%, while year-to-date (YTD) performance is -26.91%. AKYA stock has a five-year performance of %. Its 52-week range is between 8.02 and 21.84, which gives AKYA stock a 52-week price range ratio of 22.94%

Akoya BioSciences Inc. currently has a PE ratio of -6.40, a price-to-book (PB) ratio of 3.30, a price-to-sale (PS) ratio of 5.90, a price to cashflow ratio of -, a PEG ratio of 2.32, a ROA of -39.14%, a ROC of -77.37% and a ROE of -226.06%. The company’s profit margin is -85.99%, its EBITDA margin is -71.90%, and its revenue ttm is $59.60 Million , which makes it $1.59 revenue per share.

Of the last four earnings reports from Akoya BioSciences Inc., there were 1 positive earnings surprise and 3 negative earnings surprise. The company has EPS estimate of $-0.34 for the next earnings report. Akoya BioSciences Inc.’s next earnings report date is 09th Aug 2022.

The consensus rating of Wall Street analysts for Akoya BioSciences Inc. is Strong Buy (1.17), with a target price of $17.33, which is +54.87% compared to the current price. The earnings rating for Akoya BioSciences Inc. stock is (calculated from actual period earnings estimates revision (80% weight) and previous period earnings surprise (20% weight)).

Akoya BioSciences Inc. has a dividend yield of -% with a dividend per share of $- and a payout ratio of -%.

Akoya BioSciences Inc. has a Buy technical analysis rating based on Technical Indicators (ADX : 18.91, ATR14 : 1.01, CCI20 : 67.25, Chaikin Money Flow : 0.01, MACD : -0.01, Money Flow Index : 52.74, ROC : 6.17, RSI : 57.70, STOCH (14,3) : 82.95, STOCH RSI : 1.00, UO : 40.10, Williams %R : -17.05), Simple Moving Averages and Exponential Moving Averages.

Aggregated Insider Trades of Akoya BioSciences Inc. in the last 12-months were:

Analyst RatingsCurrent1 M ago3 M ago
Strong Buy
2 (66.67 %)
2 (66.67 %)
3 (75.00 %)
Moderate Buy
1 (33.33 %)
1 (33.33 %)
1 (25.00 %)
Hold
0 (0.00 %)
0 (0.00 %)
0 (0.00 %)
Moderate Sell
0 (0.00 %)
0 (0.00 %)
0 (0.00 %)
Strong Sell
0 (0.00 %)
0 (0.00 %)
0 (0.00 %)
Summary RatingStrong Buy
1.17
Strong Buy
1.17
Strong Buy
1.13

Akoya BioSciences Inc.

Akoya Biosciences Inc is an an innovative life sciences technology company. It is delivering spatial biology solutions focused on transforming discovery and clinical research. It offers the most comprehensive, end-to-end solutions for high-parameter tissue analysis from discovery through clinical and translational research, enabling the development of more precise therapies for immuno-oncology and other drug development applications.

CEO: Brian McKelligon

Telephone: +1 855 896-8401

Address: 100 Campus Drive, 6th Floor, Marlborough 01752, MA, US

Number of employees: 169

Bearish or Bullish?
WeekMonthThree MonthsSix Months

Bearish Bullish

100%0%

Bearish Bullish

65%35%

Bearish Bullish

61%39%

Bearish Bullish

61%39%

TipRanks News for AKYA

News

Stocktwits